Skip to main content

Table 1 Patient characteristics

From: In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer

 

N

Number of patients

32

Age -- (y)

 

   Median

60

   Range

34-78

Histological type

 

   serous/serous-papillary

31

   Endometrioid

1

Histological grade

 

   G 2

12

   G 3

20

Stage

 

   III C

30

   IV

2

CA 125 (U/mL)

 

   Median

1376

   Range

(86-9030)

CA 125 (U/mL) after preoperative treatment

 

   Median

71

   Range

(17-2794)

Number of chemotherapy cylcles before cytoreductive surgery

 

   Two

19

   Three

13

Residual disease after cytoreductive surgery

 

   no gross residual disease

9

   ≤ 1 cm

19

   >1 cm

4

Lymph node status

 

   N0*

13

   N1

7

   NX

12

Recurrence status (%)

 

   recurrent disease

21

   Dead

17

  1. *at least 25 lymph nodes